Clinical Trial

Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults

Study acronym: DW_DWP16001112
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated October 16, 2024 (before its estimated December 3, 2024 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the pharmacokinetic/pharmacodynamic drug-drug interactions between DWP16001, DWC202407, and DWC202408 in healthy adults
Trial Details
NCT Number NCT06644404
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Healthy
Enrollment 34 participants
Start Date 2024-10-26
Primary Completion 2024-12-03 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2024-10-16